非清细胞细胞癌的瘤结果:第三级护理中心的回顾性研究
Vijay K Bhargava1, Shaunak Valame1, Harsh Sahu1
1Medical Oncology, Jawaharlal Nehru Cancer Hospital and Research Centre, Bhopal, IND.
Cureus
|September 2, 2025
概括
这项研究强调了非清细胞细胞癌 (nccRCC) 的多样性结果,表明乳头癌和染色细胞癌亚型的预后更好,而采集管癌则更具攻击性. 组织学亚型是nccRCC治疗和生存的关键.
科学领域:
- 尿道病学
- 癌症学
- 病理学
背景情况:
- 非清细胞癌 (nccRCC) 是一组不同于清细胞癌的癌.
- nccRCC亚型在研究中代表性不足,特别是在印度人群中.
研究的目的:
- 评估初级nccRCC的临床病理特征,免疫组织化学 (IHC) 模式和瘤结果.
- 在第三级护理环境中分析不同nccRCC亚型的预后变异性.
主要方法:
- 在37名经组织学确认的nccRCC成年患者中进行了回顾性单中心研究.
- 对人口,临床,病理和IHC数据的分析.
- 卡普兰-梅尔生存分析 (DFS和OS) 与亚型比较.
主要成果:
- 乳头癌 (37. 8%) 和染色细胞癌 (21. 6%) 是最常见的;采集管癌的转移率 (80%) 和死亡率 (80%) 较高.
- 平均DFS为19个月,平均寿命为31个月.
- 五年生存率因亚型而异,染色恐惧性RCC为87. 5%,采集管癌为0%.
结论:
- 组织学亚型对于nccRCC的预后和治疗决定至关重要.
- 乳头癌和染色细胞癌具有良好的结果,而收集管道癌则表明存活率较低.
- 为了改善nccRCC的结果,特定亚型的管理,早期识别的IHC和分子分析是必不可少的.
更多相关视频
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
9.1K
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
193
相关概念视频
Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
